Raúl Ortíz-Conde 1
, Carla S. Paredes-Brito 1
, Iván J. Linares-Cervantes 1
, Esteban J. Eslava-Echagaray 1
, Galia P. Rojas-Reyna 1
, Sandy O. Nava-Fuerte 1
, Irving R. Conde-Quintanar 1 
1 Servicio de trasplante renal, Hospital General Regional, Medicina Familiar No. 1, Instituto Mexicano del Seguro Social, Cuernavaca, Morelos, México
*Correspondence: Raúl Ortíz-Conde. Email: condeor1984@gmail.com
Dengue is an arboviral disease transmitted by the Aedes aegypti mosquito, with high incidence in endemic regions such as Mexico. Its clinical course is variable, ranging from mild forms to severe complications. In the context of kidney transplantation, identifying viral infections in the donor is essential to prevent risks to the recipient. The patient presented with a febrile illness with clinical and biochemical findings consistent with dengue infection, including elevated transaminases. Dengue in kidney donors from endemic areas represents a diagnostic and safety challenge in transplantation. It is essential to perform a thorough clinical evaluation, consider travel history, prior episodes of fever or recent vaccination, and have serologic surveillance strategies in place.
Content available only in Spanish.